Try our Advanced Search for more refined results

Asahi, Actelion Throw Final Punches In Fasudil IP Row

By Erin Marie Daly (April 27, 2011, 7:57 PM EDT) -- Asahi Kasei Pharma Corp. urged a California jury on Wednesday to order Actelion Ltd. to pay hundreds of millions of dollars in damages for edging Fasudil out of the market by interfering with Asahi's license agreement with CoTherix Inc. to develop the hypertension drug, which was allegedly sidelined for safety reasons....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!